Ecolab’s Strategic Move in Pennsylvania: A Catalyst for Biotherapeutic Innovation

  In this exclusive interview with BioPharma BoardRoom, Jessay Devassy, Manager, Bioprocess Applications at Ecolab Bioprocessing&...

May 23, 2025 | Friday | Interaction
MedX Health Expands Teledermatology Footprint in Italy Through Strategic Partnership with Vitamed and Medispa

MedX Health Corp. , a global leader in teledermatology, is pleased to announce a strategic collaboration in the Italian healthcare market between Vitamed...

May 22, 2025 | Thursday | News
Microba’s MetaXplore™ GI Plus Demonstrates Clinical Impact in Over 70% of Patients With Chronic Gut Symptoms

Microba Life Sciences Limited, a precision microbiome company,  announces preliminary results from the analysis of over 4,600 MetaXplore™ GI P...

May 16, 2025 | Friday | News
Merck CEO Belén Garijo Steers Strong Q1 as Process Solutions Powers Growth and Strategic Vision

Net sales increased organically by 2.5% to € 5.3 billion EBITDA pre up organically by 5.8% to € 1.5 billion All three b...

May 15, 2025 | Thursday | Company results
Illumina Unveils DRAGEN™ v4.4 with Breakthrough Accuracy and Oncology-Ready Applications

Building on reputation for unparalleled performance, latest software delivers even greater accuracy, with 30% improvement in structural variant calling ...

May 14, 2025 | Wednesday | News
Exelixis Advances Invenra-Discovered XB628 into Phase 1 Clinical Trial for Solid Tumors

Invenra Inc., a biotechnology company specializing in the discovery and development of multispecific antibodies,  announced that its collaboration par...

May 14, 2025 | Wednesday | News
BD Launches FACSDiscover™ A8 Cell Analyzer to Redefine Flow Cytometry with Spectral and Real-Time Imaging Technologies

BD a leading global medical technology company, announced the global commercial launch of the world's first cell analyzer featuring breakthrough spectral...

May 14, 2025 | Wednesday | News
Innovo Therapeutics Completes Phase 1 Trial of INV-101, a First-in-Class Oral Immune Metabolism Modulator

Demonstrated strong safety and favorable pharmacokinetics in Phase 1 study A First-in-class oral small molecule modulating immune cell metabolism vi...

May 13, 2025 | Tuesday | News
Biocom California and KoreaBIO Sign MOU to Strengthen US-Korea Life Science Collaboration

Biocom California, the association representing the California life science industry, and KoreaBIO, a life science trade association which seeks to solid...

May 13, 2025 | Tuesday | News
Etcembly Partners with DJS Antibodies, Part of AbbVie, to Accelerate AI-Driven Antibody Discovery

British techbio innovator Etcembly has signed a collaboration agreement with DJS Antibodies, a part of AbbVie, to accelerate the discovery of novel antib...

May 13, 2025 | Tuesday | News
Conduit Pharmaceuticals Secures Korean Patent for AZD1656, Strengthening Global IP Portfolio for Autoimmune Drug

Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit Pharmaceuticals", "Conduit" or the “Company”) today announces that the Korean Intellectu...

May 12, 2025 | Monday | News
10x Genomics Reports Q1 2025 Revenue of $154.9M as CEO Serge Saxonov Shifts to Quarterly Guidance Amid Funding Uncertainty

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the first quarter ended March 31...

May 09, 2025 | Friday | Company results
Illumina Posts $1.04B in Q1 2025 Revenue as CEO Jacob Thaysen Cautions on Weaker Full-Year Outlook Amid Tariff Pressures and China Headwinds

Core Illumina revenue of $1.04 billion for Q1 2025, down 1% from Q1 2024 (flat on a constant currency basis) GAAP operating margin...

May 09, 2025 | Friday | Company results
Agilent Technologies Strengthens Presence in India and Asia with Inauguration of India Solution Center at Manesar Campus

Agilent Technologies Inc. (NYSE: A), a global leader in analytical instrumentation and laboratory solutions, today announced the official inauguration of...

May 08, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close